文献速递重症综合管理与镇静镇痛儿科与产科急症

α2受体激动剂作为儿科重症监护镇静剂的有效性:一项倾向性评分匹配队列研究

The Effectiveness of α2 Agonists As Sedatives in Pediatric Critical Care: A Propensity Score-Matched Cohort Study.
PubMed 文献 · Crit Care Med · 2019-01-01
一句话结论在两家三级PICU中,使用α2受体激动剂(可乐定和右美托咪定)的患儿机械通气期间充分镇静时间占比为74%,与匹配未使用组的70%相比达到非劣效,且过度镇静时间减少8.1%,但吗啡用量未显著减少、咪达唑仑用量反而更高。

该回顾性观察性队列研究纳入两家三级PICU的1085例患儿,按是否使用α2受体激动剂(可乐定和右美托咪定)分为暴露组和未暴露组,并用倾向性评分匹配。主要终点为机械通气期间充分镇静时间(COMFORT行为评分11–16)占比,暴露组为74%(95%CI 72–75%),未暴露组为70%(95%CI 67–72%),比值为1.06(95%CI 1.02–1.10),达到非劣效。暴露组过度镇静时间减少8.1%(95%CI 4.3–11.9%)。吗啡用量减少0.25 μg/kg/hr(95%CI -0.68至1.18 μg/kg/hr),未达统计学显著;咪达唑仑用量未减少且统计学上更高。作者结论认为,使用α2受体激动剂与匹配未暴露组充分镇静时间相似,但未观察到吗啡或苯二氮䓬类辅助用药减少,镇静有向更浅方向转移的趋势。

要点

  • 在两家三级PICU的1085例患儿中,使用α2受体激动剂(可乐定和右美托咪定)的暴露组机械通气期间充分镇静时间占比74%(95%CI 72–75%),匹配未暴露组70%(95%CI 67–72%),比值1.06(95%CI 1.02–1.10),达到非劣效。
  • 暴露组过度镇静时间较未暴露组减少8.1%(95%CI 4.3–11.9%)。
  • 吗啡用量减少0.25 μg/kg/hr(95%CI -0.68至1.18 μg/kg/hr),未达统计学显著。
  • 咪达唑仑用量未减少且统计学上更高。
  • 作者结论认为α2受体激动剂使用与匹配未暴露组充分镇静时间相似,但未减少吗啡或苯二氮䓬类辅助用药,镇静有向更浅方向转移的趋势。

适用人群与场景

  • 两家三级PICU的患儿,按是否使用α2受体激动剂(可乐定和右美托咪定)作为镇静方案的一部分分为暴露组和未暴露组,并用倾向性评分匹配。

诊断标准与关键阈值

  • 充分镇静定义为机械通气期间COMFORT行为评分11–16。
  • 过度镇静按原文分类评估。

研究设计与关键结果

  • 研究类型为回顾性观察性队列研究,纳入1085例患者,在两家三级PICU进行,暴露组接受α2受体激动剂(可乐定和右美托咪定)作为镇静方案的一部分,未暴露组未接受,两组用倾向性评分匹配。
  • 主要终点:暴露组充分镇静时间占比74%(95%CI 72–75%),未暴露组70%(95%CI 67–72%),比值1.06(95%CI 1.02–1.10),达到非劣效。
  • 次要终点:暴露组过度镇静时间较未暴露组减少8.1%(95%CI 4.3–11.9%)。
  • 吗啡用量减少0.25 μg/kg/hr(95%CI -0.68至1.18 μg/kg/hr),未达统计学显著。
  • 咪达唑仑用量未减少且统计学上更高。

证据类型、等级与局限

  • 证据类型:回顾性观察性队列研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者结论认为,使用α2受体激动剂与匹配未暴露组充分镇静时间相似,但未观察到吗啡或苯二氮䓬类辅助用药减少,镇静有向更浅方向转移的趋势。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVES: There is limited evidence supporting the widespread use of α2 agonists (clonidine and dexmedetomidine) in pediatric critical care sedation. This study sought to test the association between the use of α2 agonists and enhanced sedation.

DESIGN: A retrospective observational cohort study was conducted. Noninferiority of time adequately sedated (COMFORT Behavior Score 11-16) while mechanically ventilated was assessed. Secondarily, dosing of opioids and benzodiazepines was examined.

SETTING: Two tertiary PICUs.

PATIENTS: Children were classified into an exposed group, who received an α2 agonist as part of their sedation regimen, and an unexposed group. Groups were matched using propensity score analysis.

INTERVENTIONS: None.

MEASUREMENTS AND MAIN RESULTS: One-thousand eighty-five patients were included. The exposed group were adequately sedated 74% (95% CI, 72-75%) of the study time compared with the unexposed group at 70% (95% CI, 67-72%) giving a ratio of 1.06 (95% CI, 1.02-1.10) and a noninferior time adequately sedated. A decrease in time oversedated was observed with 8.1% (95% CI, 4.3-11.9%) less time classified as oversedated in the exposed group. Reduction in morphine use of 0.25 μg/kg/hr (95% CI, -0.68 to 1.18 μg/kg/hr) was not statistically significant. Midazolam use did not decrease and was statistically higher.

CONCLUSIONS: Use of α2 agonists was associated with similar time adequately sedated as a matched unexposed group although no reduction in morphine or benzodiazepine coadministration was observed. There was a shift toward lighter sedation with α2 agonist use.

来源:Crit Care Med,查看原文。版权归原作者所有。

参考来源

  1. Hayden JC, Doherty DR, Dawkins I, et al. The Effectiveness of α2 Agonists As Sedatives in Pediatric Critical Care: A Propensity Score-Matched Cohort Study. Crit Care Med. 2019. PMID: 31033500. doi:10.1097/CCM.0000000000003789

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。